Table 1

Characteristics of the GWASs used in this study

PhenotypeConsortiumNEthnicityGenotype dataPMID
Exposure (insulin resistance phenotypes)*
 Fasting insulin adjusted for BMIMAGICUp to 108 557 individualsEuropeanGWAS array and metabochip array22885924 to 22581228
 HDL-C and triglyceridesGLGCUp to 188 577 individualsEuropeanGWAS array and metabochip array24097068
29046328
 Insulin sensitivity for gold standard measuresGENESIS2764 individualsEuropeanGWAS array25798622
Outcomes
 Coronary artery diseaseCARDIoGRAMplusC4DUp to 184 305 individuals
(60 801 cases and 123 504 controls)
EuropeanGWAS array26343387
 Myocardial infarctionCARDIoGRAMplusC4DUp to 171 876 individuals
(43 677 cases and 128 199 controls)
EuropeanGWAS array26343387
 Ischemic strokeMEGASTROKEUp to 446 696 individuals
(40 585 cases and 406 111 controls)
EuropeanGWAS array29531354
 Large-artery atherosclerosisMEGASTROKEUp to 440 328 individuals
(34 217 cases and 406 111 controls)
EuropeanGWAS array29531354
 Small-artery occlusionMEGASTROKEUp to 411 497 individuals
(5386 cases and 406 111 controls)
EuropeanGWAS array29531354
 CardioembolismMEGASTROKEUp to 413 304 individuals
(7193 cases and 406 111 controls)
EuropeanGWAS array29531354
  • *Lotta et al2 identified 53 genetic variants for insulin resistance phenotypes by combining published GWAS results for fasting insulin adjusted for BMI, HDL-C and triglycerides, and Wang et al3 generated a composite genetic instrument for insulin resistance phenotypes by meta-analysis of these genetic variants.

  • BMI, body mass index; CARDIoGRAMplusC4D, Coronary ARtery DIsease Genome-wide Replication And Meta-Analysis Plus Coronary Artery Disease Genetics; GENESIS, GENEticS of Insulin Sensitivity; GLGC, Global Lipids Genetics Consortium; GWAS, genome-wide association study; HDL-C, high-density lipoprotein cholesterol; MAGIC, Meta-Analyses of Glucose and Insulin-related traits Consortium; MEGASTROKE, Multiancestry Genome-wide Association Study of Stroke; PMID, PubMed unique identifier.